Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.37 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PTPRC | P08575 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1828340 | 0.85 | HTT (0.39) | L3MBTL1ALDH1A1LMNAHTTCYP2C19 | |
| SCHEMBL1829363 | 0.77 | MBTD1 (0.40) | L3MBTL1MBTD1L3MBTL3ALDH1A1LMNA | |
| SCHEMBL28733603 | 0.73 | TDP1 (0.43) | L3MBTL1MBTD1L3MBTL3ALDH1A1LMNA | |
| SCHEMBL19193984 | 0.69 | L3MBTL1 (0.54) | L3MBTL1LMNACYP2C19CYP2D6PTPRC | |
| SCHEMBL27570822 | 0.69 | L3MBTL1 (0.54) | L3MBTL1LMNACYP2C19CYP2D6PTPRC | |
| SCHEMBL27551142 | 0.69 | L3MBTL1 (0.54) | L3MBTL1LMNACYP2C19CYP2D6PTPRC | |
| SCHEMBL24269352 | 0.66 | CYP2D6 (0.44) | L3MBTL1CYP2D6PTPRCMAPT | |
| SCHEMBL1830522 | 0.66 | CA12 (0.43) | L3MBTL1MBTD1L3MBTL3ALDH1A1LMNA | |
| SCHEMBL1508734 | 0.65 | CYP2D6 (0.42) | L3MBTL1CYP2D6PTPRCMAPTMEN1 | |
| SCHEMBL30937559 | 0.65 | PTPRC (0.41) | L3MBTL1ALDH1A1LMNAPTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110230419-A1 | IAP BINDING COMPOUNDS | NUEVOLUTION A/S (DK) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230419-A1 | IAP BINDING COMPOUNDS | BIRC5, BIRC7, BIRC3 | L3MBTL1 1939/4885MBTD1 3402/4885L3MBTL3 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.